Skip to main content
. 2014 Oct 22;2014:295323. doi: 10.1155/2014/295323

Table 2.

Laboratory findings at presentation.

Case WBC Hb Platelet LDH BUN Cr Crmax ADAMTS13 Plasma exchange
×109/L g/L ×109/L U/L mg/dL mg/dL mg/dL % Number of sessions
1 10.1 125 52 3,330 76 2.6 6.5 on day 3 86 17 for 19 days
2∗ 12.5 85 99 1,271 39 3.37 55 15 for 18 days
3 10.48 95 96 1,471 55 4.84 5.99 on day 32 79 1 for 1 day
4-1 13.59 71 65 910 28 2.51 4.02 on day 17 85 6 for 6 days
4-2 5.07 84 63 770 46 5.52 6.86 on day 2 0
5∗∗ 2.69 111 57 892 71 5.43 5.53 on day 2 74 5 for 6 days

*The patient was on hemodialysis at the time of transfer.

∗∗The patient received her last dose of gemcitabine and carboplatin 3 weeks before presentation.

Normal ADAMTS13 activity, >67%; Crmax: maximal serum creatinine.